You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Broad Spectrum Bitter Taste Antagonists Discovery

    SBC: DISCOVERYBIOMED, INC.            Topic: NIDCD

    Principal Investigators for Small Business: DiscoveryBioMed, Inc. (DBM) and Monell Chemical Senses Center Project Summary Abstract Bitter taste in foods and medicines presents a barrier to overcoming global public health challenges: food insecurity, poor nutritional health, and poor compliance with medication use, particularly among children and the elderly. Sugar and salt, the mainstays to addres ...

    STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  2. Electronically Dimmable Eye Protection Devices (EDEPD)

    SBC: ALPHAMICRON, INCORPORATED            Topic: AF18BT003

    Phase II research efforts focus on advancing the development of the switchable polarizer light control films for pilots and warfighters. The light control films utilize AlphaMicron's propriety liquid crystal technology to provide adjustable tint on demand with millisecond switching times, fails to clear, and excellent optics. Research efforts include the development and fabrication of single and d ...

    STTR Phase II 2020 Department of DefenseAir Force
  3. A small molecule integrin activator to enhance cord blood transplant

    SBC: 7 Hills Pharma LLC            Topic: NHLBI

    PROJECT SUMMARY This proposal is in response to the parent announcement for Phase II STTR (R42) grant applications. Hematopoietic stem cell transplantation has become a preferred treatment for hematological malignancies and certain genetic disorders. Umbilical cord blood has become an appealing alternative to bone marrow or peripheral blood as a source of hematopoietic stem cells for transplant. D ...

    STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  4. Advanced Ship-handling Simulators

    SBC: D'Angelo Technologies, LLC            Topic: N18AT014

    COVE is nearing 20 years in operation. COVE was developed as a “state-of-the-art navigation and ship handling training” system for all Surface Officers. Over the years, scenarios (ports) have been added, environments have been improved for more realistic feedback, and newer technology has been integrated but the system is still lacking the capability to provide autonomous performance assessmen ...

    STTR Phase II 2020 Department of DefenseNavy
  5. Methods for the Scaled up Production of Stabilized MXenes

    SBC: LYNNTECH INC.            Topic: AF18BT017

    The proposed R&D program is directed towards the commercialization of a new class of two-dimensional (2D) inorganic nanosheets, known as MXenes. Commercialization of these materials is a priority for maintaining the superiority of US military technology in application areas such as: field effect transistors, energy storage devices, shielding from electromagnetic interference, high performance comp ...

    STTR Phase II 2020 Department of DefenseAir Force
  6. SmallSat Stirling Cryocooler for BMDS (SSC-X)

    SBC: WECOSO, INC.            Topic: MDA17T003

    West Coast Solutions (WCS) proposes the development of the SSC-X Stirling cryocooler to enable the deployment of infrared (IR) payloads on small satellite platforms. We achieve extreme miniaturization (

    STTR Phase II 2019 Department of DefenseMissile Defense Agency
  7. Carbon Nanotube Heated Composite Tooling for High-Temperature Processing of Thermosetting and Thermoplastic Composites

    SBC: MAINSTREAM ENGINEERING CORP            Topic: N18BT031

    This proposal outlines Mainstream’s and Colorado State University’s (CSU) approach to fabricating a large-scale composite tool capable of curing composites out-of-autoclave (OOA). The use of autoclaves is the primary cost driver in composite manufacturing due to size limitations, long processing times, and inefficient energy usage. Therefore, the Navy is looking to develop a nanostructured hea ...

    STTR Phase II 2020 Department of DefenseNavy
  8. Properties Investigation of High-MON Oxidizers and MMH Blends for Use in Deep Space Exploration

    SBC: Frontier Aerospace Corporation            Topic: T9

    The REFPROP program developed by the National Institute of Standards and Technology (NIST) is a widely-used database for industrial fluid properties, including propellants used for chemical rocket propulsion.nbsp; For deep space applications, low-temperature propellants are of particular interest but accurate fluid property data was scarce or unavailable to the industry.nbsp; Recently, NASA MSFC h ...

    STTR Phase II 2020 National Aeronautics and Space Administration
  9. Integrated Platform for Mass-Spectrometric Studies of Protein Structure

    SBC: PROTEIN METRICS INC            Topic: 400

    Summary Technology for studying the higher order structure (HOS) and interactions of biomolecules is a highlighted NIGMS SBIR/STTR research topic. Mass-spectrometric methods for studying HOS include hydroxyl radical footprinting as well as chemical methods to covalently label amino acid side-chain functional groups, and also hydrogen/deuterium exchange (HDX) on protein backbone amides. These metho ...

    STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  10. HBI-002 to Prevent Anthracycline-Related Cardiotoxicity

    SBC: Hillhurst Biopharmaceuticals, Inc.            Topic: NHLBI

    PROJECT SUMMARY There is an urgent need for the development of approaches to prevent cardiotoxicity in cancer patients being treated with anthracyclines, an important class of drugs in the treatment of cancer (e.g. doxorubicin). Anthracycline treatment-related cardiotoxicity is a major clinical problem that severely impacts patient care and also limits dose and usage. More than a quarter of patien ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government